Rye and health - Where do we stand and where do we go?

被引:51
|
作者
Jonsson, Karin [1 ]
Andersson, Roger [2 ]
Knudsen, Knud Erik Bach [3 ]
Hallmans, Goran [4 ]
Hanhineva, Kati [5 ]
Katina, Kati [6 ]
Kolehmainen, Marjukka [5 ]
Kyro, Cecilie [7 ]
Langton, Maud [2 ]
Nordlund, Emilia [8 ]
Laerke, Helle Nygaard [3 ]
Olsen, Anja [7 ]
Poutanen, Kajsa [8 ]
Tjonneland, Anne [7 ]
Landberg, Rikard [1 ]
机构
[1] Chalmers Univ Technol, Food & Nutr Sci, Biol & Biol Engn, SE-41296 Gothenburg, Sweden
[2] Swedish Univ Agr Sci, Dept Mol Sci, POB 7015, SE-75007 Uppsala, Sweden
[3] Aarhus Univ, Dept Anim Sci, DK-8830 Tjele, Denmark
[4] Umea Univ, Dept Publ Hlth & Clin Med, Nutr Res, Umea, Sweden
[5] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, POB 1627, Kuopio 70211, Finland
[6] Univ Helsinki, Dept Food & Nutr, Agnes Sjobergin Katu 2, FIN-00014 Helsinki, Finland
[7] Danish Canc Soc Res Ctr, DK-2100 Copenhagen, Denmark
[8] VTT Tech Res Ctr Finland Ltd, POB 1000, Oulu 02044, Finland
关键词
Weight management; Blood lipid; Inflammation; Insulin; Fiber; WHOLE-GRAIN RYE; POSTPRANDIAL GLUCOSE-METABOLISM; DOSE-RESPONSE METAANALYSIS; ALL-CAUSE MORTALITY; DIETARY FIBER; REFINED WHEAT; ENTEROLACTONE CONCENTRATIONS; CONCENTRATED ARABINOXYLAN; SOURDOUGH FERMENTATION; CHOLESTEROL EXCRETION;
D O I
10.1016/j.tifs.2018.06.018
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Background: High whole grain intake has consistently been associated with lowered risk of developing a number of chronic diseases. Among cereals, rye has highest content of dietary fiber, together with a wide variety of bioactive compounds. There is accumulating evidence from intervention studies of physiological effects of rye foods with potential health benefits. Scope and approach: This review summarizes the state of the art of rye and health and identifies future directions for research and innovation, based partly on findings presented at the international conference "The Power of Rye", angstrom land, Finland, 7-8 June 2017. Key findings and conclusions: Rye foods have well-established beneficial effects on insulin metabolism compared with wheat bread under isocaloric conditions and at standardized amounts of available carbohydrates, which may have positive implications for diabetes prevention. Recent findings suggest that alterations in blood glucose flux partly explain these effects. Moreover, several studies have shown beneficial effects of rye-based foods on satiety, which is one plausible mechanism behind recently demonstrated beneficial effects on weight management. Emerging results indicate beneficial effects of rye intake on inflammation and blood lipids. More research is needed to uncover underlying mechanisms for other demonstrated effects and the long-term implications for health. A challenge with rye-based foods is making them palatable and widely acceptable to consumers. Development of innovative and tasty rye products and targeted communication strategies is crucial in increasing awareness and consumption of rye foods. Novel results in this regard are presented in this review.
引用
收藏
页码:78 / 87
页数:10
相关论文
共 50 条
  • [1] Gephyrin: where do we stand, where do we go?
    Fritschy, Jean-Marc
    Harvey, Robert J.
    Schwarz, Guenter
    [J]. TRENDS IN NEUROSCIENCES, 2008, 31 (05) : 257 - 264
  • [2] ColVI myopathies: where do we stand, where do we go?
    Allamand, Valerie
    Brinas, Laura
    Richard, Pascale
    Stojkovic, Tanya
    Quijano-Roy, Susana
    Bonne, Gisele
    [J]. SKELETAL MUSCLE, 2011, 1
  • [3] Investigative dermatology: where do we stand and where do we go?
    Maurer, M.
    von Stebut, E.
    [J]. EXPERIMENTAL DERMATOLOGY, 2010, 19 (10) : 857 - 857
  • [4] ColVI myopathies: where do we stand, where do we go?
    Valérie Allamand
    Laura Briñas
    Pascale Richard
    Tanya Stojkovic
    Susana Quijano-Roy
    Gisèle Bonne
    [J]. Skeletal Muscle, 1
  • [5] Treatment of negative symptoms: Where do we stand, and where do we go?
    Aleman, Andre
    Lincoln, Tania M.
    Bruggeman, Richard
    Melle, Ingrid
    Arends, Johan
    Arango, Celso
    Knegtering, Henderikus
    [J]. SCHIZOPHRENIA RESEARCH, 2017, 186 : 55 - 62
  • [6] Where do we stand on neuroprotection? Where do we go from here?
    Shoulson, I
    [J]. MOVEMENT DISORDERS, 1998, 13 : 46 - 48
  • [7] THE CYTOGENETICS OF RENAL TUMORS - WHERE DO WE STAND, WHERE DO WE GO
    WALTER, TA
    BERGER, CS
    SANDBERG, AA
    [J]. CANCER GENETICS AND CYTOGENETICS, 1989, 43 (01) : 15 - 34
  • [8] THE DECADE OF TOTAL QUALITY - WHERE DO WE STAND - WHERE DO WE GO
    YEAGER, R
    [J]. PIMA MAGAZINE, 1994, 76 (03): : S2 - S3
  • [9] Occupational Rhinitis and Asthma: Where Do We Stand, Where Do We Go?
    Castano, Roberto
    Malo, Jean-Luc
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2010, 10 (02) : 135 - 142
  • [10] RED ALGAL SPECIES: WHERE DO WE STAND, WHERE DO WE GO?
    Zuccarello, G. C.
    [J]. PHYCOLOGIA, 2013, 52 (04) : 127 - 128